ANNE FEASTER: Open Payments
NPI 1932259652 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,836 in 65 payments from 28 companies in 2025. Trend: 2023 $4,277 · 2024 $3,372 · 2025 $1,836
Food & beverage: $1,813Education: $23
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| Genmab U.S., Inc. | 2 | $147 |
| GlaxoSmithKline, LLC. | 6 | $142 |
| Gilead Sciences, Inc. | 1 | $120 |
| Daiichi Sankyo Inc. | 5 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| BeOne Medicines USA, Inc. | 3 | $85 |
| ABBVIE INC. | 3 | $80 |
| Incyte Corporation | 3 | $79 |
| Janssen Biotech, Inc. | 3 | $74 |
Products named: Epkinly, Enhertu, Trodelvy, BRUKINSA, Lenvima, XPOVIO, ELAHERE, OJJAARA.
Industry payments across PA — which companies pay providers there.
